Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Interest Expenses (2021)

Krystal Biotech (KRYS) has disclosed Interest Expenses for 1 consecutive years, with $1.5 million as the latest value for Q1 2021.

  • Quarterly Interest Expenses changed N/A to $1.5 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2021, changed N/A year-over-year, with the annual reading at $1.5 million for FY2021, N/A changed from the prior year.
  • Interest Expenses hit $1.5 million in Q1 2021 for Krystal Biotech.
  • In the past five years, Interest Expenses ranged from a high of $1.5 million in Q1 2021 to a low of $1.5 million in Q1 2021.